ATOSSA THERAPEUTICS ANNOUNCES PLAN TO ISSUE STAPLED CVR FOR SHAREHOLDERS TIED TO POTENTIAL RARE PEDIATRIC DISEASE PRIORITY REVIEW VOUCHER

Reuters · 1d ago

Please log in to view news